Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

The findings, which were presented at the 50th Annual Oncology Nursing Society Congress, showed that at a median follow-up of ...

Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal of Clinical ...

Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't ...

In a live virtual event, Attaya Suvannasankha, MD, discussed the MajesTEC-1 trial of teclistamab and approaches to mitigation of cytokine release syndrome. Marc Raab, MD, PhD, discussed the MajesTEC-5 ...

Johnson & Johnson and Legend Biotech’s BCMA-targeted CAR-T therapy Carvykti has been approved by the FDA to treat patients with multiple myeloma after at least one prior therapy. The decision ...

Multiple myeloma (MM) is an incurable and biologically diverse blood cancer that begins with the uncontrolled growth of plasma cells in the bone marrow. One of plasma’s main roles is to produce ...

1 Multiple myeloma originates in blood plasma cells ... a randomised trial to determine the impact of stem cell dose on symptoms in this patient population. Dr Shah has been heavily involved ...

Recent findings indicate that annual low-dose whole-body computed tomography (WBLDCT) significantly contributes to the management of smoldering multiple myeloma (SMM). A study published in the Journal ...

TUESDAY, April 22, 2025 (HealthDay News) — Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published ...